한국어
English
日本語
中文(简体)
Edurant 25 mg (Rilpivirine Hydrochloride)
27.5mg
Tablet · Prescription medication
Janssen Korea Co., Ltd.
Rilpivirine hydrochloride is an antiretroviral ingredient used in the treatment of HIV infection.
MFDS ingredient code M253921
Rilpivirine hydrochloride belongs to the class of non-nucleoside reverse transcriptase inhibitors. It is primarily used to inhibit the replication of the HIV-1 virus in the treatment of infection. This component aims to reduce the viral load in patients with HIV infection.
Rilpivirine hydrochloride blocks the reverse transcriptase enzyme that the HIV virus needs to replicate its genetic material. This prevents the virus from multiplying within cells, thereby inhibiting the spread of the infection.
Approved uses differ by product. Check each product's information for its actual use.
Unlike other antiretroviral drugs, Rilpivirine hydrochloride acts as a non-nucleoside reverse transcriptase inhibitor by directly binding to the active site of the enzyme. This medication has a low incidence of resistance development and offers high convenience for administration, making it favorable for sustained treatment.
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Even with the same ingredient, dosage and approved uses can differ by strength, dosage form and combined ingredients. Check each product's information before taking it.
Ingredients used together with this ingredient in combination products.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
Product approval information is based on drug information provided by the Ministry of Food and Drug Safety.
Ingredient and class descriptions are not part of MFDS data and were written separately by Cashdoc.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.